184 related articles for article (PubMed ID: 6646313)
1. A behavioral assessment of arcuate nucleus damage after a single injection of monosodium glutamate.
Dawson R; Annau Z
Neurobehav Toxicol Teratol; 1983; 5(4):399-406. PubMed ID: 6646313
[TBL] [Abstract][Full Text] [Related]
2. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse.
Lorden JF; Caudle A
Neurobehav Toxicol Teratol; 1986; 8(5):509-19. PubMed ID: 3785512
[TBL] [Abstract][Full Text] [Related]
3. Neonatal exposure to monosodium glutamate alters the neurobehavioral performance of adult rats.
Squibb RE; Tilson HA; Meyer OA; Lamartiniere CA
Neurotoxicology; 1981 Nov; 2(3):471-84. PubMed ID: 7199686
[TBL] [Abstract][Full Text] [Related]
4. Behavioral deficits in adult rats treated neonatally with glutamate.
Hlinák Z; Gandalovicová D; Krejcí I
Neurotoxicol Teratol; 2005; 27(3):465-73. PubMed ID: 15939206
[TBL] [Abstract][Full Text] [Related]
5. The Monosodium L-glutamate (MSG) syndrome in mice develops independently of housing condition.
Barnhart JE; Pizzi WJ
Neurobehav Toxicol Teratol; 1982; 4(5):549-56. PubMed ID: 7177307
[TBL] [Abstract][Full Text] [Related]
6. [Transplacental neurotoxic effects of monosodium glutamate on structures and functions of specific brain areas of filial mice].
Gao J; Wu J; Zhao XN; Zhang WN; Zhang YY; Zhang ZX
Sheng Li Xue Bao; 1994 Feb; 46(1):44-51. PubMed ID: 8085168
[TBL] [Abstract][Full Text] [Related]
7. Central but not peripheral glucoprivation is impaired in monosodium glutamate-treated rats.
de Andrade IS; Gonzalez JC; Hirata AE; Carneiro G; Amado D; Cavalheiro EA; Dolnikoff MS
Neurosci Lett; 2006 May; 398(1-2):6-11. PubMed ID: 16406310
[TBL] [Abstract][Full Text] [Related]
8. Naloxone-induced suppression of food intake is potentiated by neonatal administration of monosodium glutamate to mice.
Dawson R
Neurobehav Toxicol Teratol; 1983; 5(5):523-6. PubMed ID: 6664410
[TBL] [Abstract][Full Text] [Related]
9. Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain.
Yu L; Zhang Y; Ma R; Bao L; Fang J; Yu T
Eur Neuropsychopharmacol; 2006 Apr; 16(3):170-7. PubMed ID: 16257184
[TBL] [Abstract][Full Text] [Related]
10. Perinatal MSG treatment attenuates fasting-induced bradycardia and metabolic suppression.
Messina MM; Evans SA; Swoap SJ; Overton JM
Physiol Behav; 2005 Oct; 86(3):324-30. PubMed ID: 16153669
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects on behaviour after postnatal treatment with monosodium-L-glutamate.
Klingberg H; Brankack J; Klingberg F
Biomed Biochim Acta; 1987; 46(10):705-11. PubMed ID: 3446198
[TBL] [Abstract][Full Text] [Related]
12. Reproductive dysfunction in male rats following neonatal administration of monosodium L-glutamate.
Pizzi WJ; Barnhart JE; Unnerstall JR
Neurobehav Toxicol; 1979; 1(1):1-4. PubMed ID: 551297
[TBL] [Abstract][Full Text] [Related]
13. Monosodium glutamate neonatal treatment as a seizure and excitotoxic model.
López-Pérez SJ; Ureña-Guerrero ME; Morales-Villagrán A
Brain Res; 2010 Mar; 1317():246-56. PubMed ID: 20043888
[TBL] [Abstract][Full Text] [Related]
14. The neuronal cell types in the arcuate nucleus in normal and monosodium glutamate treated rats: a Golgi study.
Schiethart L; Marani E; Rietveld WJ; Van Ingen J
Acta Morphol Neerl Scand; 1983 Dec; 21(4):285-91. PubMed ID: 6670595
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and neurochemical effects of neonatal administration of monosodium L-glutamate in mice.
Dawson R; Lorden JF
J Comp Physiol Psychol; 1981 Feb; 95(1):71-84. PubMed ID: 7217414
[TBL] [Abstract][Full Text] [Related]
16. Temporal and spatial expression of preprotachykinin A mRNA in the developing filial mice brain after maternal administration of monosodium glutamate at a late stage of pregnancy.
Xu L; Zhao Y; Zhan SQ; Tang XD; Guo Y; Wang HS; Yang C
Neuroscience; 2007 Mar; 145(3):974-80. PubMed ID: 17307297
[TBL] [Abstract][Full Text] [Related]
17. Effect of cholecystokinin on feeding is attenuated in monosodium glutamate obese mice.
Maletínská L; Toma RS; Pirnik Z; Kiss A; Slaninová J; Haluzík M; Zelezná B
Regul Pept; 2006 Sep; 136(1-3):58-63. PubMed ID: 16782213
[TBL] [Abstract][Full Text] [Related]
18. The significance of excursions above the ADI. Case study: monosodium glutamate.
Walker R
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S119-21. PubMed ID: 10597625
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Tang-Christensen M; Vrang N; Larsen PJ
Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
[TBL] [Abstract][Full Text] [Related]
20. Monosodium L-glutamate in soup reduces subsequent energy intake from high-fat savoury food in overweight and obese women.
Miyaki T; Imada T; Hao SS; Kimura E
Br J Nutr; 2016 Jan; 115(1):176-84. PubMed ID: 26455957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
